{
    "2020-09-30": [
        [
            {
                "time": "",
                "original_text": "智飞生物(300122.SZ)：持股5%以上股东吴冠江减持1%股份 减持股份",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "吴冠江",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "智飞生物(300122.SZ)主要股东吴冠江减持1600万股 减持比例已达1% 减持股份",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "吴冠江",
                        "减持",
                        "1600万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：吴冠江减产比例达总股本1%",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "吴冠江",
                        "减产",
                        "总股本"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "子公司具备重组新冠疫苗生产条件和资格 智飞生物全力以赴诠释大国企业担当",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "重组新冠疫苗",
                        "生产条件",
                        "大国企业"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【行情】疫苗板块开盘走高，博晖创新大涨10%，赛升药业、智飞生物、海利生物等跟涨",
                "features": {
                    "keywords": [
                        "疫苗板块",
                        "开盘走高",
                        "博晖创新",
                        "智飞生物",
                        "海利生物"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "疫苗股反弹，智飞生物涨超4%",
                "features": {
                    "keywords": [
                        "疫苗股",
                        "反弹",
                        "智飞生物"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}